ArticlePLoS pathogens2026
PRRSV-2 impedes lysosomes from eliminating secondary infected bacteria.
Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- PRRSV suppresses ER-phagy through Nsp2- and Nsp5-mediated degradation of FAM134B.Frontiers in cellular and infection microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As an immunosuppressive virus, the occurrence of secondary bacterial infection following porcine reproductive and respiratory syndrome virus type 2 (PRRSV-2) infection is widely recognized. The immune escape capability of PRRSV-2 enables the virus to maintain efficient proliferation even within macrophages. In this study, we report that PRRSV-2 infection disrupts the intracellular F-actin, thereby causing the inability of macrophage lysosomes to transport to secondary infected bacteria promptly for bacterial clearance. RhoA is a crucial molecule in the polymerization of G-actin to F-actin within the cell. Silencing RhoA suppresses the production of F-actin in the cell, delays the targeted clearance of bacteria by lysosomes, and leads to an increase in the number of viable bacteria within the cell. Overexpression of RhoA promotes the production of F-actin, accelerates the targeted clearance of lysosomes to bacteria, and effectively reduces the number of viable bacteria. After PRRSV-2 infection, the expression of RhoA protein is down-regulated by nsp5 to inhibit the production of F-actin. Mechanistically, nsp5 interacts with the E3 ubiquitin ligase Smurf1 to mediate K63-linked ubiquitination of RhoA at lysine 187 (K187), which subsequently leads to its degradation via the autophagy-lysosome pathway under the guidance of the selective autophagy receptor TOLLIP. Therefore, our study presents a novel mechanism through which PRRSV-2 reprograms the cytoskeleton to facilitate the survival of bacteria in secondary infections, providing a theoretical foundation and target for the prevention and control of PRRSV-2 secondary bacterial infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.